119 related articles for article (PubMed ID: 16832099)
1. Pilot study of the combination of EGFR and mTOR inhibitors in recurrent malignant gliomas.
Doherty L; Gigas DC; Kesari S; Drappatz J; Kim R; Zimmerman J; Ostrowsky L; Wen PY
Neurology; 2006 Jul; 67(1):156-8. PubMed ID: 16832099
[TBL] [Abstract][Full Text] [Related]
2. Antagonism of the mammalian target of rapamycin selectively mediates metabolic effects of epidermal growth factor receptor inhibition and protects human malignant glioma cells from hypoxia-induced cell death.
Ronellenfitsch MW; Brucker DP; Burger MC; Wolking S; Tritschler F; Rieger J; Wick W; Weller M; Steinbach JP
Brain; 2009 Jun; 132(Pt 6):1509-22. PubMed ID: 19416948
[TBL] [Abstract][Full Text] [Related]
3. Phase II study of metronomic chemotherapy for recurrent malignant gliomas in adults.
Kesari S; Schiff D; Doherty L; Gigas DC; Batchelor TT; Muzikansky A; O'Neill A; Drappatz J; Chen-Plotkin AS; Ramakrishna N; Weiss SE; Levy B; Bradshaw J; Kracher J; Laforme A; Black PM; Folkman J; Kieran M; Wen PY
Neuro Oncol; 2007 Jul; 9(3):354-63. PubMed ID: 17452651
[TBL] [Abstract][Full Text] [Related]
4. Silencing mammalian target of rapamycin signaling by small interfering RNA enhances rapamycin-induced autophagy in malignant glioma cells.
Iwamaru A; Kondo Y; Iwado E; Aoki H; Fujiwara K; Yokoyama T; Mills GB; Kondo S
Oncogene; 2007 Mar; 26(13):1840-51. PubMed ID: 17001313
[TBL] [Abstract][Full Text] [Related]
5. Epidermal growth factor receptor inhibitors in neuro-oncology: hopes and disappointments.
Brandes AA; Franceschi E; Tosoni A; Hegi ME; Stupp R
Clin Cancer Res; 2008 Feb; 14(4):957-60. PubMed ID: 18281526
[TBL] [Abstract][Full Text] [Related]
6. Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08.
Wen PY; Yung WK; Lamborn KR; Dahia PL; Wang Y; Peng B; Abrey LE; Raizer J; Cloughesy TF; Fink K; Gilbert M; Chang S; Junck L; Schiff D; Lieberman F; Fine HA; Mehta M; Robins HI; DeAngelis LM; Groves MD; Puduvalli VK; Levin V; Conrad C; Maher EA; Aldape K; Hayes M; Letvak L; Egorin MJ; Capdeville R; Kaplan R; Murgo AJ; Stiles C; Prados MD
Clin Cancer Res; 2006 Aug; 12(16):4899-907. PubMed ID: 16914578
[TBL] [Abstract][Full Text] [Related]
7. Rarity of PTEN deletions and EGFR amplification in malignant gliomas of childhood: results from the Children's Cancer Group 945 cohort.
Pollack IF; Hamilton RL; James CD; Finkelstein SD; Burnham J; Yates AJ; Holmes EJ; Zhou T; Finlay JL;
J Neurosurg; 2006 Nov; 105(5 Suppl):418-24. PubMed ID: 17328268
[TBL] [Abstract][Full Text] [Related]
8. Analysis of EGFR overexpression, EGFR gene amplification and the EGFRvIII mutation in Portuguese high-grade gliomas.
Viana-Pereira M; Lopes JM; Little S; Milanezi F; Basto D; Pardal F; Jones C; Reis RM
Anticancer Res; 2008; 28(2A):913-20. PubMed ID: 18507036
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic inhibition of the epidermal growth factor receptor in high-grade gliomas: where do we stand?
Karpel-Massler G; Schmidt U; Unterberg A; Halatsch ME
Mol Cancer Res; 2009 Jul; 7(7):1000-12. PubMed ID: 19584260
[TBL] [Abstract][Full Text] [Related]
10. A feasibility and efficacy study of rapamycin and erlotinib for recurrent pediatric low-grade glioma (LGG).
Yalon M; Rood B; MacDonald TJ; McCowage G; Kane R; Constantini S; Packer RJ
Pediatr Blood Cancer; 2013 Jan; 60(1):71-6. PubMed ID: 22434731
[TBL] [Abstract][Full Text] [Related]
11. Phase I/II study of erlotinib and temsirolimus for patients with recurrent malignant gliomas: North American Brain Tumor Consortium trial 04-02.
Wen PY; Chang SM; Lamborn KR; Kuhn JG; Norden AD; Cloughesy TF; Robins HI; Lieberman FS; Gilbert MR; Mehta MP; Drappatz J; Groves MD; Santagata S; Ligon AH; Yung WK; Wright JJ; Dancey J; Aldape KD; Prados MD; Ligon KL
Neuro Oncol; 2014 Apr; 16(4):567-78. PubMed ID: 24470557
[TBL] [Abstract][Full Text] [Related]
12. Correlation of the response of recurrent malignant gliomas treated with interferon alpha with tumor interferon alpha gene content.
Olson JJ; James CD; Lawson D; Hunter S; Tang G; Billingsley J
Int J Oncol; 2004 Aug; 25(2):419-27. PubMed ID: 15254740
[TBL] [Abstract][Full Text] [Related]
13. Radiotherapy in lung adenocarcinoma with brain metastases: effects of activating epidermal growth factor receptor mutations on clinical response.
Gow CH; Chien CR; Chang YL; Chiu YH; Kuo SH; Shih JY; Chang YC; Yu CJ; Yang CH; Yang PC
Clin Cancer Res; 2008 Jan; 14(1):162-8. PubMed ID: 18172267
[TBL] [Abstract][Full Text] [Related]
14. Amplification of KIT, PDGFRA, VEGFR2, and EGFR in gliomas.
Puputti M; Tynninen O; Sihto H; Blom T; Mäenpää H; Isola J; Paetau A; Joensuu H; Nupponen NN
Mol Cancer Res; 2006 Dec; 4(12):927-34. PubMed ID: 17189383
[TBL] [Abstract][Full Text] [Related]
15. Prognostic stratification of patients with anaplastic gliomas according to genetic profile.
Dehais C; Laigle-Donadey F; Marie Y; Kujas M; Lejeune J; Benouaich-Amiel A; Pedretti M; Polivka M; Xuan KH; Thillet J; Delattre JY; Sanson M
Cancer; 2006 Oct; 107(8):1891-7. PubMed ID: 16986124
[TBL] [Abstract][Full Text] [Related]
16. Malignant gliomas: strategies to increase the effectiveness of targeted molecular treatment.
Wen PY; Kesari S; Drappatz J
Expert Rev Anticancer Ther; 2006 May; 6(5):733-54. PubMed ID: 16759164
[TBL] [Abstract][Full Text] [Related]
17. High-dose methotrexate in malignant gliomas.
Shapiro WR
Cancer Treat Rep; 1977 Jul; 61(4):753-6. PubMed ID: 301785
[No Abstract] [Full Text] [Related]
18. Phase II study of spirohydantoin mustard for the treatment of recurrent malignant gliomas.
Prados M; Rodriguez L; Seager M; Silver P; Levin V
Cancer Treat Rep; 1987 Nov; 71(11):1105-6. PubMed ID: 3119204
[No Abstract] [Full Text] [Related]
19. Molecular targeting for malignant gliomas (Review).
Kondo Y; Hollingsworth EF; Kondo S
Int J Oncol; 2004 May; 24(5):1101-9. PubMed ID: 15067331
[TBL] [Abstract][Full Text] [Related]
20. Interstitial infusion of erlotinib in the rodent brain.
Luther N; Karampelas I; Souliopoulos EP; Edgar MA; Boockvar JA; Souweidane MM
J Exp Ther Oncol; 2009; 8(2):79-84. PubMed ID: 20192114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]